187 related articles for article (PubMed ID: 12074328)
21. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
[TBL] [Abstract][Full Text] [Related]
22. The role of preoperative axillary ultrasound and fine-needle aspiration cytology in identifying patients with extensive axillary lymph node involvement.
Maráz R; Zombori T; Ambrózay É; Cserni G
Eur J Surg Oncol; 2017 Nov; 43(11):2021-2028. PubMed ID: 28919032
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of carcinoma in palpable vs impalpable, mammographically detected lesions.
Bassett LW; Liu TH; Giuliano AE; Gold RH
AJR Am J Roentgenol; 1991 Jul; 157(1):21-4. PubMed ID: 1646562
[TBL] [Abstract][Full Text] [Related]
24. Axillary ultrasound and fine-needle aspiration in the preoperative evaluation of the breast cancer patient: an algorithm based on tumor size and lymph node appearance.
Mainiero MB; Cinelli CM; Koelliker SL; Graves TA; Chung MA
AJR Am J Roentgenol; 2010 Nov; 195(5):1261-7. PubMed ID: 20966338
[TBL] [Abstract][Full Text] [Related]
25. Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?
Pilewskie M; Jochelson M; Gooch JC; Patil S; Stempel M; Morrow M
J Am Coll Surg; 2016 Feb; 222(2):138-45. PubMed ID: 26711795
[TBL] [Abstract][Full Text] [Related]
26. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
27. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
28. New therapeutic possibilities in primary invasive breast cancer.
Cady B; Stone MD; Wayne J
Ann Surg; 1993 Sep; 218(3):338-47; discussion 347-9. PubMed ID: 8373276
[TBL] [Abstract][Full Text] [Related]
29. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer.
Oruwari JU; Chung MA; Koelliker S; Steinhoff MM; Cady B
Am J Surg; 2002 Oct; 184(4):307-9. PubMed ID: 12383889
[TBL] [Abstract][Full Text] [Related]
30. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
31. Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?
Specht MC; Fey JV; Borgen PI; Cody HS
J Am Coll Surg; 2005 Jan; 200(1):10-4. PubMed ID: 15631914
[TBL] [Abstract][Full Text] [Related]
32. Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients.
Rosen PP; Kimmel M
Hum Pathol; 1990 May; 21(5):518-23. PubMed ID: 2338331
[TBL] [Abstract][Full Text] [Related]
33. Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.
Chung MH; Ye W; Giuliano AE
Ann Surg Oncol; 2001 Oct; 8(9):688-92. PubMed ID: 11597008
[TBL] [Abstract][Full Text] [Related]
34. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
35. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
[TBL] [Abstract][Full Text] [Related]
36. Role of axillary dissection in mammographically detected breast cancer.
Jamali FR; Kurtzman SH; Deckers PJ
Surg Oncol Clin N Am; 1997 Apr; 6(2):343-58. PubMed ID: 9115500
[TBL] [Abstract][Full Text] [Related]
37. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.
Mignano JE; Zahurak ML; Chakravarthy A; Piantadosi S; Dooley WC; Gage I
Cancer; 1999 Oct; 86(7):1258-62. PubMed ID: 10506712
[TBL] [Abstract][Full Text] [Related]
38. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
[TBL] [Abstract][Full Text] [Related]
39. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
[TBL] [Abstract][Full Text] [Related]
40. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
